11C-meta-hydroxyephedrine: A promising PET radiopharmaceutical for imaging the sympathetic nervous system

Clinical Nuclear Medicine

Volumn 40, Issue 2, 2015, Pages e96-e103

  Boschi, Stefano ^a   Lodi, Filippo ^a   Boschi, Laura ^a   Nanni, Cristina ^a   Chondrogiannis, Sotirios ^b   Colletti, Patrick M ^c   Rubello, Domenico ^b,c   Fanti, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

11C meta hydroxyephedrine; cardiac imaging; CNS imaging; PET; positron emission tomography

Indexed keywords

3 HYDROXYEPHEDRINE; CARBON 11; CARBON 11 META HYDROXYEPHEDRINE; NORADRENALIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 3-HYDROXYEPHEDRINE; EPHEDRINE;

ADRENERGIC SYSTEM; AUTONOMIC INNERVATION; DRUG MECHANISM; DRUG SYNTHESIS; HEART; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART INNERVATION; HEART OUTPUT; HEART RATE; HUMAN; NEUROBLASTOMA; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION; ANALOGS AND DERIVATIVES; DIAGNOSTIC USE; SCINTISCANNING;

EPHEDRINE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84940225213     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000000512     Document Type: Review

References (67)

1. Zipes DP. Autonomic modulation of cardiac arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, PA: W.B. Saunders Company; 1995: 441-442
2. Carrió I. Cardiac neurotransmission imaging. J Nucl Med. 2001;42:1062-1076
3. Bristow M, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta adrenergic receptor density in human failing hearts. N Engl J Med. 1982;307:205-211
4. Eisenhofer G, Smolich JJ, Cox HS, et al. Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog. Circulation. 1991;84:1354-1363
5. Eisenhofer G, Friberg P, Rundqvist B, et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation. 1996;93:1667-1676
6. Wieland DM, Brown LE, Rogers WL, et al. Myocardial imaging with a radio-iodinated norepinephrine storage analog. J Nucl Med. 1981;22:22-31
7. Hattori N, Schwaiger M. Metaiodobenzylguanidine scintigraphy of the heart: what have we learnt clinically? Eur J Nucl Med. 2000;27:1-6
8. Vallabhajosula S, Nikolopoulou A. Radioiodinated metaiodobenzylguanidine [MIBG]: radiochemistry, biology, and pharmacology. Semin Nucl Med. 2011; 41:324-333
9. Chirumamilla A, Travin MI. Cardiac applications of #sup#123#/sup#I-mIBG imaging. Semin Nucl Med. 2011;41:374-387
10. Thackeray JT, Bengel FM. Assessment of cardiac autonomic neuronal function using PET imaging. J Nucl Cardiol. 2013;20:150-165
11. Degrado TR, Zalutsky MR, Vaidyanathan G. Uptake mechanisms of meta-[#sup#123#/sup#I]iodobenzylguanidine in isolated rat heart. Nucl Med Biol. 1995; 22:1-12
12. DeGrado TR, Hutchins GD, Toorongian SA, et al. Myocardial kinetics of carbon-11-meta-hydroxyephedrine: retention mechanisms and effects of nor-epinephrine. J Nucl Med. 1993;34:1287-1293
13. Rosenspire KC, Haka MS, Van Dort ME, et al. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nuc I Med. 1990;31:1328-1334
14. Schwaiger M, Hutchins GD, Wieland DM. Noninvasive evaluation of the cardiac sympathetic nervous system with positron emission tomography. In: Bergmann SR, Sobel BE, eds. Positron Emission Tomography of the Heart. Mount Kisco, NY: Futura Publishing; 1992:231-254
15. Luisi AJ Jr, Suzuki G, deKemp R, et al. Regional #sup#11#/sup#C-hydroxyephedrine retention in hibernating myocardium: chronic inhomogeneity of sympathetic innervation in the absence of infarction. J Nucl Med. 2005;46: 1368-1374
16. Raffel DM, Chen W, Sherman PS, et al. Dependence of cardiac #sup#11#/sup#c-meta-hydroxyephedrine retention on norepinephrine transporter density. J Nucl Med. 2006;47:1490-1496
17. Thackeray JT, Beanlands RS, Dasilva JN. Presence of specific #sup#11#/sup#C-meta-hydroxyephedrine retention in heart, lung, pancreas, and brown adipose tissue. J Nucl Med. 2007;48:1733-1740
18. Link JM, Synovec RE, Krohn KA, et al. High speed liquid chromatography of phenylethanolamines for the kinetic analysis of [11C]-meta-hydroxyephedrine and metabolites in plasma. J Chromatogr B Biomed Sci Appl. 1997;693: 31-41
19. Bengel FM, Schwaiger M. Assessment of cardiac sympathetic neuronal function using PET imaging. J Nucl Cardiol. 2004;11:603-616
20. Schwaiger M, Kalff V, Rosenspire K, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation. 1990;82:457-464
21. Luisi AJ Jr, Fallavollita JA, Suzuki G, et al. Spatial inhomogeneity of sympathetic nerve function in hibernating myocardium. Circulation. 2002;106: 779-781
22. Matsunari I, Aoki H, Nomura Y, et al. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging. 2010;3:595-603
23. Somsen GA, Verberne HJ, Fleury E, et al. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: Implications for clinical studies. J Nucl Cardiol. 2004;11:126-133
24. Morozumi T, Kusuoka H, Fukuchi K, et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med. 1997;38:49-52
25. Simoes MV, Barthel P, Matsunari I, et al. Presence of sympathetically dener-vated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. Eur Heart J. 2004;25:551-557
26. Nomura Y, Matsunari I, Takamatsu H, et al. Quantitation of cardiac sympathetic innervation in rabbits using #sup#11#/sup#C-hydroxyephedrine PET: relation to #sup#123#/sup#I-MIBG uptake. Eur J Nucl Med Mol Imaging. 2006;33:871-878
27. Na°gren K, Müller L, Halldin C, et al. Improved synthesis of some commonly used PET radioligands by the use of [#sup#11#/sup#C] methyl triflate. Nucl Med Biol. 1995; 22:235-239
28. Lodi F, Carpinelli A, Malizia C, et al. Synthesis of [#sup#11#/sup#C]-meta-hydroxyephedrine ([#sup#11#/sup#C]MHED). In: Scott PJ, Hocley BG eds. Radiochemical Syntheses, Vol 1: Radiopharmaceuticals for Positron Emission Tomography. New York: J. Wiley & Sons Inc.; 2012:191-198
29. Langstrom B, Lunquvist H. The preparation of [#sup#11#/sup#C] methyl iodide and its use in the synthesis of [#sup#11#/sup#C] methyl-L-methionine. Int J Appl Radiat Isot. 1976; 27:357-363
30. Crouzel C, Langstrom B, Pike VW, et al. Recommendations for practical production of [#sup#11#/sup#C] methyl iodide. Appl Radiat Isot. 1987;38:601-603
31. Larsen P, Ulin J, Dahlstrom K, et al. Synthesis of [#sup#11#/sup#C] Iodomethane by iodina-Tion of [#sup#11#/sup#C] methane. Appl Radiat Isot. 1997;48:153-157
32. Link JM, Clark JC, Larsen P, et al. Production of [#sup#11#/sup#C] methyl iodide by reaction of [#sup#11#/sup#C]CH#inf#4#/inf# with I#inf#2#/inf#. J Labelled Comp Radiopharm. 1995;37:76-78
33. Jewett DM. A simple synthesis of [#sup#11#/sup#C] methyl triflate. Appl Radiat Isot. 1992; 43:1383-1385
34. Hartmann F, Ziegler S, Nekolla S, et al. Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography. Heart. 1999;81: 262-270
35. Vesalainen RK, Pietila M, Tahvanainen KU, et al. Cardiac positron emission tomography imaging with [11C]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure. Am J Cardiol. 1999;84:568-574
36. Bengel FM, Thackeray JT. Altered cardiac innervation predisposes to ventricular arrhythmiaVtargeted positron emission tomography identifies risk in ischemic cardiomyopathy. J Am Coll Cardiol. 2014;63:150-152
37. Goldstein DS, Holmes CS, Li ST, et al. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med. 2000;133;338-347
38. Li ST, Tack CJ, Fananapazir L, et al. Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2000;35:1867-1873
39. Odaka K, von Scheidt W, Ziegler SI, et al. Reappearance of cardiac presyn-Aptic sympathetic nerve terminals in the transplanted heart: correlation between PET using [11]C-hydroxyephedrine and invasively measured norepinephrine release. J Nucl Med. 2001;42:1011-1016
40. Allman KC, Wieland DM, Muzik O, et al. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol. 1993;22:368-375
41. Bulow HP, Stahl F, Lauer B, et al. Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction. Nucl Med Commun. 2003;24: 233-239
42. Backs J, Haunstetter A, Gerber SH, et al. The neuronal norepinephrine transporter in experimental heart failure: evidence for a post-Transcriptional down-regulation. J Mol Cell Cardiol. 2001;33:461-472
43. Bengel FM, Ueberfuhr P, Schiepel N, et al. Myocardial efficiency and sympathetic re-innervation after orthotopic heart transplantation: a noninvasive study with positron emission tomography. Circulation. 2001;103:1881-1886
44. Ungerer M, Hartmann F, Karoglan M, et al. Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation. 1998;97:174-180
45. Di Carli MF, Tobes MC, Mangner T, et al. Effects of cardiac sympathetic in-nervation on coronary blood flow. N Engl J Med. 1997;336:1208-1215
46. Fuccio C, Nanni C, Martignani C, et al. #sup#11#/sup#C-HED PET/CT variation of cardiac adrenergic activity in patients with idiopathic heart failure disease after CRT. Eur J Nucl Med Mol Imaging. 2011;37:34-42
47. Schafers M, Lerch H, Wichter T, et al. Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. J Am Coll Cardiol. 1998;32:181-186
48. Calkins H, Allman K, Bolling S, et al. Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart. Circulation. 1993;88:172-179
49. Fallavollita JA, Heavey BM, Luisi AJ Jr, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic car-diomyopathy. J Am Coll Cardiol. 2014;63:141-149
50. Fallavollita JA, Heavey BM, Baldwa S, et al. Volume of denervated myocardium is a novel predictor of VT/VF: prediction of arrhythmic events with positron emission tomography [PAREPET] study. Heart Rhythm. 2012; 9:LB01
51. Kies P, Wichter T, Schäfers M, et al. Abnormal myocardial presynaptic nor-epinephrine recycling in patients with Brugada syndrome. Circulation. 2004; 110:3017-3022
52. Calkins H, Lehmann MH, Allman K, et al. Scintigraphic pattern of regional cardiac sympathetic innervation in patients with familial long QT syndrome using positron emission tomography. Circulation. 1993;87:1616-1621
53. Goldstein DS. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol. 2003;2:669-676
54. Berding G, Schrader CH, Peschel T, et al. [N-methyl 11C]meta-hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging. 2003;30:127-131
55. Stevens MJ, Raffel DM, Allman KC, et al. Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism. 1999;48:92-101
56. Pop-Busui R, Kirkwood I, Schmid H, et al. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and dia-stolic dysfunction. J Am Coll Cardiol. 2004;44:2368-2374
57. Wong KK, Raffel DM, Koeppe RA, et al. Pattern of cardiac sympathetic de-nervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET. Radiology. 2012;265:240-247
58. Langer O, Halldin C. PET and SPET tracers for mapping the cardiac nervous system. Eur J Nucl Med Mol Imaging. 2002;29:416-434
59. Shulkin BL, Wieland DM, Schwaiger M, et al. PET scanning with hydro-xyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med. 1992;33:1125-1131
60. Shulkin BL, Wieland DM, Baro ME, et al. PET hydroxyephedrine imaging of neuroblastoma. J Nucl Med. 1996;37:16-21
61. Trampal C, Engler H, Juhlin C, et al. Pheochromocytomas: detection with C-11 hydroxyephedrine PET. Radiology. 2004;230:423-428
62. Franzius C, Hermann K, Weckesser M, et al. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT. J Nucl Med. 2006;47:1635-1642
63. Yamamoto S, Hellman P, Wassberg C, et al. 11C-hydroxyephedrine positron emission tomography imaging of pheochromocytoma: a single center experience over 11 years. J Clin Endocrinol Metab. 2012;97:2423-2432
64. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277-359
65. Cinti S. The adipose organ: morphological perspectives of adipose tissues. Proc Nutr Soc. 2001;60:319-328
66. Quarta C, Lodi F, Mazza R, et al. 11C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-To-brown fat conversion. Mol Metab. 2013;2:153-160
67. Ouellet V, Labbé SM, Blondin DP, et al. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest. 2012;122:545-552